Viewing nowDiamicron MR 60 mg (Gliclazide)
Gliclazide 60mg
Tablet · Prescription medication
Korea Servier Co., Ltd.

MFDS item code 201004772 · Approved 2010.07.30 · Insurance code 676300120
Treatment of type 2 diabetes mellitus inadequately controlled by diet and exercise
This medication is used for patients with type 2 diabetes who do not achieve sufficient results from diet and exercise alone. It helps control blood sugar levels and contributes to stabilizing blood sugar levels, supporting healthy blood sugar management.
Adults: Administer gliclazide orally once daily in the morning at a dose of 30~120mg, adjusted according to blood glucose levels. It is recommended that this medicine be swallowed whole without crushing or chewing. Do not increase the dose the following day if a dose is missed. When used with other blood glucose-lowering medicines, adjust the dose according to the individual patient's metabolic response (blood glucose, glycated hemoglobin). * Initial dose The recommended initial dose is 30mg daily. - If blood glucose control is satisfactory, maintain this dose. - If blood glucose control is unsatisfactory, the dose may be gradually increased to 60, 90, and 120 mg daily at intervals of at least 1 month. If blood glucose has not decreased after 15 days of treatment, increase the dose from the end of the second week of treatment. Do not exceed 120mg daily. * Switching from gliclazide 80mg to this medicine (gliclazide modified-release tablets 60mg): For patients stabilized on gliclazide 80mg, administer this medicine according to the principle “gliclazide 80mg = gliclazide modified-release tablets 30mg.” * Switching from another oral blood glucose-lowering medicine to this medicine (gliclazide modified-release tablets 60mg): This medicine (gliclazide modified-release tablets 60mg) may replace another oral blood glucose-lowering medicine. When switching, consider the dose and half-life of the previous blood glucose-lowering medicine. In general, switching can be done without any transitional washout period; start this medicine at 30mg daily and gradually increase the dose according to each patient's metabolic response as described under “Initial dose.” For patients switching from a sulfonylurea blood glucose-lowering medicine with a long half-life, a washout period of several days is required to prevent the risk of hypoglycemia due to the additive effects of the two medicines. * Concomitant use with other oral blood glucose-lowering medicines This medicine may be used concomitantly with biguanides, α-glucosidase inhibitors, or insulin. In patients whose condition is not adequately controlled with this medicine, concomitant treatment with insulin may be initiated under close medical supervision. * Elderly patients This medicine may be prescribed in the same manner as for patients aged 65 years or younger. * Patients with renal impairment In patients with mild or moderate renal impairment, this medicine may be prescribed in the same manner as for patients with normal renal function, with careful patient monitoring. * Patients at risk of hypoglycemia - Undernourished or malnourished state - Severe or decompensated endocrine disorders (anterior pituitary insufficiency, hypothyroidism, corticotropin insufficiency) - Discontinuation of long-term and/or high-dose corticosteroid therapy - Severe vascular disease (severe coronary heart disease, severe carotid artery disease, diffuse vascular disease) → It is recommended to initiate treatment at the minimum dose of 30mg daily.
This drug is a sulfonylurea that lowers blood sugar, but it carries a risk of hypoglycemia, so caution is needed. In particular, severe hypoglycemia can lead to coma, so strict adherence to dosages is necessary. This drug should not be administered to patients with diabetic ketoacidosis, diabetic coma, type 1 diabetes, severe liver or kidney function impairment, patients with severe infections or post-operative patients, or those with gastrointestinal disorders. Additionally, it should not be used in patients with known allergic reactions to this drug or similar drugs, pregnant or breastfeeding women, or patients with certain genetic lactose metabolism disorders. Caution should also be exercised in patients who are uncooperative, elderly, suffer from mild to moderate kidney or liver function impairment, certain endocrine disorders, poor nutritional status or irregular eating habits, vigorous exercisers, or excessive drinkers as they are at a higher risk for hypoglycemia. During treatment, watch for symptoms of hypoglycemia such as weakness, headache, confusion, sweating, palpitations, and consume carbohydrates immediately if symptoms occur. Immediate medical care is necessary for severe hypoglycemia, and in some cases, hospitalization may be required. This drug may also cause side effects such as hematological abnormalities, liver dysfunction, gastrointestinal symptoms, skin rashes, temporary visual disturbances, so consult healthcare professionals if these symptoms occur. This drug is used when diet and exercise do not provide sufficient effectiveness, and regular checks of blood sugar and urine sugar should be conducted to monitor effectiveness and side effects. Moreover, this drug can interact with multiple medications, so inform your healthcare professional of any other drugs you are taking. Particularly, it should not be used concurrently with drugs such as miconazole, and alcohol intake should also be avoided. Pregnant or potentially pregnant women and breastfeeding mothers should not use this medication, and safety in children has not been established. Elderly patients are at higher risk for hypoglycemia and should be administered with greater caution and undergo regular testing. In cases of overdose, symptoms of hypoglycemia may occur, so immediate emergency treatment should be sought, as self-treatment can be dangerous. While taking this medication, caution should be exercised regarding hypoglycemic symptoms when driving or operating machinery, and it should be stored out of reach of children.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. It is important to maintain storage temperatures between 1 and 30 degrees Celsius.
White, oval extended-release tablet with a score line marked “DIA60" on both sides.
90 tablets (15 tablets/PTP x 6)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowGliclazide 60mg
Tablet · Prescription medication
Korea Servier Co., Ltd.

Gliclazide 80mg
Tablet · Prescription medication
(Samchundang Pharmaceuticals Co., Ltd.)

Gliclazide 80mg
Tablet · Prescription medication
(Shinil Pharmaceutical Co., Ltd.)

Gliclazide 80mg
Tablet · Prescription medication
(Samnam Pharmaceutical Co., Ltd.)
Gliclazide 80mg
Tablet · Prescription medication
SK Chemicals Co., Ltd.

Gliclazide 80mg
Tablet · Prescription medication
Teragen Itex Co., Ltd.

Gliclazide 30mg
Tablet · Prescription medication
Korea Servier Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.